Muira Puama: Dose, Formulations and Safety

This page has to do something slightly unusual, which is to be useful about a herb whose dose is not established, whose active constituent is unknown, and whose formal toxicology is almost entirely missing. The temptation in that situation is to fill the gaps — to quote a milligram range as though someone had determined it, or to invent a hazard so the safety section has something in it. Both are failures, in opposite directions.

So: the absence of data is written here as a finding, not as a gap for you to infer. Where a number cannot be sourced, this page says so and says why. Where a hazard is theoretical rather than documented, it is labelled theoretical. And where the genuine risk lies — which for muira puama is not the plant at all but the shelf it sits on — that gets the space it deserves. The concrete danger attached to a muira puama purchase is that sexual-enhancement supplements are the product category most often found adulterated with undeclared prescription erectile-dysfunction drugs, and that risk has nothing to do with the bark.

Table of Contents

1. The Short Answer
2. Why There Is No Established Dose
3. What Labels Say, and What That Is Worth
4. The Traditional Preparation: Prolonged Boiling
5. Solvent Substitution: Tincture Is Not Tea
6. What Is Actually In It
7. The Coumarin Check, Run Explicitly
8. The Beta-Sitosterol Check
9. The Real Risk on This Shelf
10. What Toxicology Exists
11. Numbered Findings: The Missing Safety Data
12. Interaction Concerns, Honestly Rated
13. Pregnancy, Breastfeeding and Children
14. Hazards Muira Puama Does Not Have
15. Practical Guidance
16. Safety Ledger
17. Key Research Papers
18. External Resources
19. Connections

The Short Answer

• There is no evidence-based dose. No dose-finding study has been done in humans. Label figures come from tradition and manufacturers, not from research, and this page will not launder them into a recommendation.
• The traditional preparation is a prolonged decoction of woody bark and root, or a spirit maceration. Both make sense given that much of the plant's chemistry is poorly water-soluble — and they are not equivalent to each other.
• Formal toxicology is largely absent. No published human single-herb safety study, no reproductive toxicology, no long-term data. Long traditional use is genuine reassurance of a weak kind and is not a safety study.
• The documented category risk is adulteration with sildenafil or tadalafil in sexual-enhancement products. This is the concrete, evidence-backed hazard, and it is a product hazard rather than a plant hazard.
• Real theoretical concerns exist around blood pressure, platelets, cholinergic drugs and antidepressants — each labelled theoretical below, each with its reasoning shown.
• Avoid in pregnancy and breastfeeding, on the grounds that there is no data at all rather than on the grounds of a known harm.

Back to Table of Contents

Why There Is No Established Dose

A dose is not a folk quantity; it is the output of a specific research process. That process has four stages and muira puama has completed none of them.

1. Identify the active constituent. Not done. The preclinical page works through the candidates; the honest position is that nobody knows which compound produces the observed effects.
2. Establish pharmacokinetics in humans. Not done. No absorption data, no plasma concentrations, no half-life, no idea whether once or three times daily makes sense.
3. Find a dose-response relationship for a defined outcome. Not done, because there is no validated human outcome to plot against.
4. Establish a safe upper limit from toxicology. Not done, in humans.

Without those, a number on a label is a filling quantity chosen for manufacturing convenience and market convention. That is not a scandal — it is true of most traditional botanicals — but it should be named accurately rather than dressed up. We are deliberately not printing a recommended milligram range here, and the reason is that stating one would be a guess wearing the costume of a finding.

There is a further reason to refuse it that is specific to this plant. Dose figures are usually expressed as milligrams of "muira puama," which conflates at least four different things: dried bark powder, dried root powder, a hydroalcoholic extract at an undisclosed concentration ratio, and a "standardised" extract standardised to a marker that cannot even confirm the species. A milligram figure that does not say milligrams of what is not a dose. It is a weight.

Back to Table of Contents

What Labels Say, and What That Is Worth

You can still make sense of a label without treating it as evidence, and knowing what the format tells you is more useful than a number would be.

• "500 mg muira puama (bark)" — crude powder, and the most honest format, because it states a real quantity of a stated part. It also means you get only the fraction your gut extracts, and the studied material was an ethanol extract, so the relationship to the research is unknown.
• "4:1 extract, 250 mg" — meaningful only if the ratio is honest and the solvent stated. Extraction ratios are among the least policed numbers in the industry, and a ratio says nothing about which compounds were captured.
• "Standardised to X% sterols" — a potency claim about a pan-plant compound class. It tells you nothing about identity, as the identity page explains, and nothing about the constituents anyone thinks are interesting.
• "Proprietary blend, 1,200 mg" with muira puama in a list — no usable information whatsoever. The content could be a meaningful fraction or a dusting. This is also the format most associated with the adulteration problem below.
• Tincture, "1:5 in 40% alcohol, 2–4 mL" — at least chemically coherent, since alcohol takes the lipophilic fraction water leaves behind. The volume is still convention, not a determined dose.

Back to Table of Contents

The Traditional Preparation: Prolonged Boiling

Muira puama is not a leaf you steep. The traditional article is bark and root-wood, and the traditional preparation reflects that: it is simmered, often for a considerable time, rather than infused for a few minutes. That distinction between a decoction (boiled, for hard woody material) and an infusion (steeped, for leaves and flowers) is genuine pharmacognosy, not fussiness — woody tissue is dense and lignified, and brief contact with hot water extracts very little from it.

Two practical consequences follow, and one of them is a genuine safety point rather than a preparation tip.

The extraction consequence. Much of what has been reported from this plant — sterols, long-chain fatty-acid esters, a volatile oil, diterpenes — is lipophilic and poorly water-soluble. Prolonged boiling improves matters at the margin but cannot make an oily compound water-soluble. So a traditional decoction plausibly delivers a different and probably much smaller fraction of the plant's chemistry than the ethanol extract used in the research. Anyone drinking the tea on the strength of the rodent studies is relying on an assumption nobody has tested.

The preparation-safety consequence. Prolonged boiling of bark chips is a domestic hazard in the ordinary way — a pot boiling dry, a scald — and, more relevantly, a long extraction is also an efficient extraction of anything unwanted in the material, including heavy metals accumulated by a woody plant and any contamination picked up in an unregulated wild-harvest chain. This is not a claim that muira puama is contaminated; it is the observation that a long hot-water extraction does not discriminate between what you want and what you do not.

Back to Table of Contents

Solvent Substitution: Tincture Is Not Tea

This deserves its own heading because it is the easiest error to miss on this plant — the species matches, the plant part matches, the common name matches, and the intervention is still different.

The published pharmacology on Ptychopetalum olacoides overwhelmingly used ethanol extracts. The tradition includes both a water decoction and a spirit maceration. Ethanol and water pull different fractions out of woody tissue: ethanol takes the lipophilic material, water takes tannins, sugars and whatever polar compounds are present. These are not weaker and stronger versions of the same thing — they are different preparations with overlapping but distinct contents.

Which means each of the following is a distinct intervention, and evidence for one is not evidence for another:

• an ethanol extract given to a mouse (what was studied);
• a hydroalcoholic tincture taken by a person (chemically closest to the research);
• a long water decoction (the traditional preparation, chemically furthest from the research);
• a capsule of raw dried powder (a fourth thing again — extraction now happens in your gut, in unknown proportion).

If you are choosing between them on the basis of the science, the tincture is the closest match to what was actually tested. If you are choosing on the basis of tradition, the decoction is. Those two answers point in different directions, and no study has compared them.

Back to Table of Contents

What Is Actually In It

The honest headline: the active principle is not established. Compounds have been identified; none has been convincingly tied to any of the claimed effects at any achievable dose. What the literature names:

• Plant sterols — beta-sitosterol and campesterol prominent among them. Ubiquitous across the plant kingdom.
• Long-chain fatty acids and their esters, a large share of the woody material by weight. No proposed pharmacology relevant to any claim.
• A volatile (essential) oil, giving the wood its aroma.
• Coumarin, plus tannins.
• Diterpenes, notably ptychonal — the structurally distinctive chemistry of the genus, of interest for nerve-growth-factor-related activity, and by far the least studied part.
• An aromatic alkaloid reported in older literature as "muirapuamine", whose characterisation is thin and which we are not going to describe pharmacologically because we cannot source anything solid about it.

Quantities are the missing column. Nowhere in the accessible literature is there a reliable figure for how much coumarin, how much sterol or how much diterpene is present per gram of bark, let alone per capsule, let alone how much varies between the traded species. That absence is why the two checks below matter so much: without quantities, any argument that "it contains X, therefore it does what X does" is unfalsifiable, and unfalsifiable arguments are exactly what fills the gap where data should be.

Back to Table of Contents

The Coumarin Check, Run Explicitly

Muira puama is reported to contain coumarin, and this fact gets used online to assert that the herb thins the blood and should not be combined with warfarin. That inference is wrong, and it is wrong in an instructive way.

Plain coumarin is not an anticoagulant. The compound that anticoagulates is dicoumarol, which forms when sweet clover spoils — microbial action on coumarin during mouldy fermentation produces the dimeric molecule that depletes vitamin-K-dependent clotting factors. That discovery is the origin of warfarin. The parent compound in fresh plant material does not share the activity. A plant containing coumarin has no more claim to be a blood thinner than a plant containing cellulose has to be paper.

The confusion is compounded by the drug class being called "coumarin anticoagulants," which makes the inference sound almost definitional. It is not.

Two things this check does not excuse:

• Coumarin has its own toxicology, and it is hepatic rather than haemostatic. At pharmaceutical doses, coumarin has produced liver enzyme elevations in a susceptible minority of people — this is well documented from clinical use of coumarin as a drug in its own right and is why regulators limit coumarin intake from flavourings such as cassia cinnamon. Whether muira puama delivers a meaningful coumarin dose is unknown, because nobody has published the quantity. The right conclusion is "unquantified, plausibly trivial, not zero," not "coumarin, therefore liver risk" and not "coumarin, therefore harmless."
• A bleeding caution can still be reasonable on other grounds. If you are on an anticoagulant and considering an unstandardised botanical of uncertain species with no interaction studies, caution is justified — by unmeasurable dose and an asymmetric downside, not by this mechanism. Getting the reasoning right matters, because a wrong mechanism invites a wrong reassurance later.

One more point specific to this herb: most bleeding warnings you will see attached to muira puama products actually belong to Ginkgo biloba, its most common formulation partner. Ginkgo has genuine antiplatelet activity and a real interaction literature. When a blend carries a bleeding caution, check which ingredient earned it.

Back to Table of Contents

The Beta-Sitosterol Check

The second recurring inference runs: muira puama contains beta-sitosterol, beta-sitosterol has documented effects on prostate symptoms and cholesterol, therefore muira puama has those effects.

This fails on two counts and the second is the more important.

First, quantity. The beta-sitosterol trials used isolated phytosterol preparations at doses in the range of tens to hundreds of milligrams daily, and the cholesterol work uses grams of plant sterols. Whether a capsule of bark powder delivers a meaningful fraction of that is unknown and, given that sterols are minor constituents of woody tissue, unlikely. No quantity figure exists to check.

Second, and decisively: beta-sitosterol is a plant-kingdom compound, so a beta-sitosterol result is not a muira puama result. It occurs in a vast range of plants and foods. If the sterol were doing the work, the herb would be an expensive and inconvenient delivery vehicle for something available far more cheaply, and every claim made for muira puama on that basis would apply equally to a great many other plants. Crediting a herb with the pharmacology of its most generic constituent is one of the most common ways a botanical claim gets inflated, and it is worth recognising because it recurs across the whole supplement shelf.

Back to Table of Contents

The Real Risk on This Shelf

Everything above concerns a plant that has no documented pattern of serious harm. This section concerns the thing that actually sends people to hospital from this product category, and it is worth stating without hedging.

Sexual-enhancement supplements are the product category most frequently found adulterated with undeclared pharmaceutical drugs. Regulatory analytical programmes and independent laboratory surveys have repeatedly identified sildenafil, tadalafil, vardenafil and unapproved analogues of them in products sold as purely herbal. This is not a theoretical concern, not a rare event, and not a fringe finding — it is one of the best-documented facts about the supplement market, and public regulatory warning lists carry a continuous stream of these products.

Why this matters specifically for a muira puama buyer:

• The dose is uncontrolled. Undeclared drug content in seized products has ranged from a fraction of a therapeutic dose to several times one. You cannot titrate what you do not know you are taking.
• The nitrate interaction can be fatal. PDE5 inhibitors combined with nitrate medications — nitroglycerin for angina, isosorbide, and recreational alkyl nitrites — can cause profound, life-threatening hypotension. This is the single most dangerous scenario in the entire supplement market, and it is precisely a man with cardiac disease, who takes nitrates and who has been told not to take erectile-dysfunction drugs, who is most likely to reach for a "natural" alternative.
• Other contraindications apply invisibly. People with unstable cardiac disease, severe hypotension, recent stroke or certain retinal conditions are advised against PDE5 inhibitors. None of them knows to apply that advice to a herbal capsule.
• It makes an untested herb feel like it works. An adulterated product produces a real, dramatic, drug-mediated effect that the buyer attributes to the plant — and then recommends. This is a mechanism by which a herb with no efficacy evidence acquires enthusiastic testimonials, and it is worth naming.
• Blends are the highest-risk format. The proprietary-blend label that hides the dose is also the format that hides an added drug.

The FDA's health-fraud pages maintain public lists of products found to contain hidden drug ingredients; checking a product against them before buying takes a minute. The same problem is documented in detail for two neighbouring herbs on this site, at tongkat ali and epimedium.

Back to Table of Contents

What Toxicology Exists

Very little, and what exists is a formula study rather than a herb study.

The one piece of published human tolerability data we can point to concerns Catuama, the Brazilian four-herb product combining Paullinia cupana (guarana), Trichilia catigua (catuaba), Ptychopetalum olacoides (muira puama) and Zingiber officinale (ginger). A clinical toxicology study of that extract in healthy volunteers appeared in Phytotherapy Research around 2005. It is a genuinely useful data point — a formal human safety evaluation is more than most traditional botanicals ever receive — and it needs three labels attached:

• Formula substitution. The intervention is four herbs. A clean tolerability result for the blend does not establish tolerability for muira puama alone, and the muira puama dose within it is not a figure a reader can extract and apply.
• Guarana complicates the read in both directions. Guarana carries caffeine. Any stimulant-type effect or adverse event in such a study has an obvious candidate cause that is not muira puama — which makes the blend look worse than the bark on stimulant endpoints, and simultaneously means a clean result on other endpoints cannot be assigned to any single component.
• Healthy volunteers, short duration. The population least likely to show a problem, over a period too short to detect anything cumulative. This is the standard and appropriate design for a phase-one-style evaluation and it is not a chronic safety study.

Beyond that: the traditional record is long and does not carry a signal of serious harm, which is worth something. But "no case reports" in a herb of this profile mainly reflects absent surveillance. Muira puama is usually taken sporadically, often inside multi-ingredient products, frequently bought online, by people who would not connect a symptom to it and whose clinician would never hear the herb's name. A reporting system that would have to survive all of that is not a system that would detect a moderate signal.

Back to Table of Contents

Numbered Findings: The Missing Safety Data

Stated as results rather than left for the reader to infer. Each is a study that could exist and does not.

1. No single-herb human safety study. The only human tolerability data is for a four-herb formula.
2. No published acute or subchronic oral toxicity study establishing a no-observed-adverse-effect level for a defined extract that we can locate.
3. No reproductive or developmental toxicology. This is why the pregnancy advice below rests on absent data rather than on a known hazard.
4. No human pharmacokinetics. Nothing is known about absorption, plasma levels, half-life, metabolism or excretion in people.
5. No cytochrome P450 or drug-transporter interaction studies. Which means the honest statement is not "no known interactions" but "no interaction study has been performed" — a phrase that means the opposite of what shoppers assume it means.
6. No dose-finding study of any kind, for any indication.
7. No hepatotoxicity surveillance specific to this herb, and no published quantification of its coumarin content.
8. No contaminant survey of commercial material for heavy metals, pesticides or microbial load — relevant for a wild-harvested woody drug that is often extracted by prolonged boiling.
9. No paediatric data at all.
10. No data on chronic use. Every scrap of human exposure information concerns short-term use.

Back to Table of Contents

Interaction Concerns, Honestly Rated

Each of the following is theoretical — derived from the plant's reported pharmacology, not from a documented interaction — and each is rated so you can weigh it rather than simply obey it.

• Cholinesterase inhibitors and cholinergic drugs. This is the best-reasoned concern on the list, because it derives from the herb's own best-documented preclinical activity: if an extract inhibits acetylcholinesterase, then combining it with donepezil, rivastigmine or galantamine is pharmacologically additive by construction, and combining it with anticholinergic drugs would be opposing. Note the structure — the proposed benefit and the proposed interaction are the same property described twice. Anyone taking a prescribed cholinesterase inhibitor, or an anticholinergic for bladder or Parkinson's symptoms, should raise this with a pharmacist. Rated: theoretical, but mechanistically the strongest.
• Blood-pressure and cardiac medication. The herb has a stimulant reputation and a documented central stimulant profile in rodents, and it is habitually sold alongside genuine stimulants. Caution in people on antihypertensives or with arrhythmia is reasonable on those grounds. Rated: theoretical, moderate, partly inherited from the products rather than the plant.
• Antiplatelet and anticoagulant drugs. Justified by unmeasurable dose and asymmetric downside — not by the coumarin content, for the reasons given above. And check whether the caution actually belongs to ginkgo in the blend. Rated: theoretical, weak mechanism, sensible precaution.
• Antidepressants. The rodent antidepressant-like profile raises a theoretical question about combining it with prescribed antidepressants. Worth noting that no monoamine-oxidase or serotonergic mechanism has been demonstrated for this plant, so this is a caution built on a behavioural assay rather than on a known pathway. Rated: theoretical, weak.
• Anything with a narrow therapeutic index. Because no cytochrome P450 or transporter data exists, the interaction potential with drugs such as warfarin, ciclosporin, tacrolimus, lithium or antiepileptics is simply unknown. Unknown is a worse position than "known to interact," because it cannot be planned around. Rated: unassessable, which is the honest rating.

Back to Table of Contents

Pregnancy, Breastfeeding and Children

Avoid in pregnancy and while breastfeeding. The reasoning matters as much as the advice, so here it is plainly: this is not because muira puama is known to harm a pregnancy. It is because there is no reproductive toxicology, no developmental data, no data on transfer into breast milk, and no case series — and in that state of complete ignorance the risk calculus is asymmetric. The potential benefit is a tonic effect that has never been demonstrated in anyone; the potential cost is unbounded because it has never been looked for.

The same logic applies to children, with the added point that a stimulant-reputation herb marketed for adult sexual function has no plausible paediatric indication in the first place.

It is worth flagging that some herbs' common names quietly imply reproductive safety they do not have. Muira puama's do not — "potency wood" makes a claim about effect, not about gentleness — so the name is not doing any misleading work here. That check comes back clear, and a clear result is worth reporting.

Back to Table of Contents

Hazards Muira Puama Does Not Have

Refusing to invent hazards is as much a part of accuracy as reporting real ones. A reader arriving from other herb pages may reasonably wonder about each of the following, and each is being explicitly cleared — on present evidence, and with the caveat that "cleared" here means "no basis for the concern," not "proven absent."

• No pyrrolizidine alkaloids. Not associated with the hepatotoxic alkaloids of comfrey, coltsfoot and borage; nothing from those pages reads across. No aristolochic acid and no nephrotoxicity signal. No thiaminase, no nutrient-depletion effect, no anthraquinones and no stimulant-laxative action.
• No cyanogenic glycosides. Unlike damiana, which carries a genuine if much-overstated cyanogenic question, no such constituent is reported here.
• No duration cap on active-moiety grounds. Some herbs need a hard time limit because the active compound is itself the hazard — uva ursi and hydroquinone being the standard case. Nothing about muira puama's chemistry implies that.
• No documented hepatotoxicity signal. Despite the coumarin content, no pattern of liver injury has been reported. The coumarin question above is a "quantity unknown" flag, not an allegation.
• No established hormonal activity. Despite the marketing, no human hormonal effect has been demonstrated in either direction — so there is no evidence-based reason to warn hormone-sensitive patients away from it specifically, and none to promise them anything either.

What is left after all that clearing is a plant with little formal safety data and no documented pattern of serious harm — sitting inside a product category with a real and well-documented adulteration problem. Those two sentences describe different risks, and keeping them separate is the single most useful thing this page can do.

Back to Table of Contents

Practical Guidance

1. Buy a single-herb product that names the species and plant part. Blends hide the dose and are the format most associated with drug adulteration — so check regulatory warning lists before buying, particularly anything sold for sexual performance or promising rapid results.
2. Treat "rapid, dramatic, drug-like effect" as a warning sign, not a testimonial. A herbal capsule producing a reliable pharmaceutical-grade result is the clinical presentation of adulteration.
3. If you take nitrates for angina, do not use sexual-performance supplements at all. This is the one piece of unhedged advice on the page. The combination that can kill is nitrate plus a PDE5 inhibitor, and the whole point of an undeclared ingredient is that you will not know it is there.
4. Tincture if you are following the science, decoction if you are following the tradition — and know you are choosing between two different preparations, not two strengths of one. Start low, and treat any stimulant-type effect — racing heart, agitation, poor sleep — as a reason to stop.
5. Tell your clinician and pharmacist you are taking it, especially alongside cardiac, psychiatric, anticoagulant or cholinesterase-inhibitor prescriptions. The interaction data does not exist, which makes disclosure more important rather than less.
6. Do not use it to manage a symptom that needs evaluating. New erectile difficulty is a recognised early cardiovascular marker; persistent fatigue and cognitive change have long differential diagnoses. See erectile dysfunction, chronic fatigue syndrome and low testosterone. Of everything on this page, delayed diagnosis is the most likely way muira puama actually harms someone.

Back to Table of Contents

Safety Ledger

1. Adulteration with undeclared PDE5 inhibitors: ESTABLISHED, HUMAN, CATEGORY-LEVEL. The best-evidenced hazard associated with buying this product, and not a property of the plant.
2. Delayed diagnosis of a treatable condition: ESTABLISHED AS A MECHANISM, unquantified for this herb.
3. Acute toxicity of the plant: NO SIGNAL, WEAK SURVEILLANCE. Long traditional use, no formal study, reporting systems unlikely to detect a moderate problem.
4. Cholinergic drug interaction: THEORETICAL, strongest mechanism on the list, and derived from the herb's own best-documented activity.
5. Cardiovascular and blood-pressure caution: THEORETICAL, partly inherited from co-formulated stimulants.
6. Bleeding risk: THEORETICAL AND WEAK, justified by unmeasurable dose rather than by coumarin content; usually belongs to ginkgo in the blend.
7. Hepatic risk from coumarin: UNQUANTIFIED. Content per gram never published; no liver signal reported.
8. Pregnancy and breastfeeding: NO DATA. AVOID. Absent evidence, asymmetric downside.
9. Chronic use: NO DATA.
10. Contaminants in wild-harvested woody material: UNSURVEYED.

Read as a whole, the ledger says something that the marketing and the alarmism both get wrong: the three best-established facts about muira puama safety are that the plant has no documented harm signal, that almost nothing has been formally studied, and that the shelf it sits on has a real adulteration problem. Two of those three are facts about ignorance and commerce rather than about the plant.

Back to Table of Contents

Key Research Papers

PubMed topic searches rather than fixed records, with provenance labelled at each citation.

1. Oliveira CH and colleagues. "Clinical toxicology study of an herbal medicinal extract of Paullinia cupana, Trichilia catigua, Ptychopetalum olacoides and Zingiber officinale (Catuama) in healthy volunteers." Phytotherapy Research, 2005. Find on PubMed — human, four-herb formula. The only human tolerability data touching this plant. Formula substitution applies, and guarana's caffeine confounds any stimulant-type endpoint.
2. Undeclared sildenafil and tadalafil in sexual-enhancement supplements. PubMed topic search — analytical, human-relevant. The evidence base for the category risk described above; the most practically important literature on this page.
3. Nitrate and PDE5 inhibitor interaction. PubMed topic search — clinical pharmacology. Why an undeclared PDE5 inhibitor is dangerous rather than merely dishonest.
4. Coumarin, dicoumarol and the anticoagulant mechanism. PubMed topic search — pharmacology. The basis for rejecting the "contains coumarin, therefore thins blood" inference.
5. Coumarin hepatotoxicity and intake limits. PubMed topic search — toxicology. Where the real coumarin concern lies, and why the missing quantification for muira puama matters.
6. Siqueira IR and colleagues. "Ptychopetalum olacoides, a traditional Amazonian 'nerve tonic', possesses anticholinesterase activity." Pharmacology, Biochemistry and Behavior, 2003. Find on PubMed — rodent and enzyme. Cited here for the interaction implication rather than the benefit: this is the mechanism behind the cholinergic caution.
7. da Silva AL and colleagues. "Anxiogenic properties of Ptychopetalum olacoides Benth. (Marapuama)." Phytotherapy Research, 2002. Find on PubMed — rodent behaviour. The basis for treating agitation or poor sleep as a plausible rather than fanciful adverse effect.
8. Bucek EU, Fournier G, Dadoun H. "Volatile constituents of Ptychopetalum olacoides root oil." Planta Medica, 1987. Find on PubMed — chemistry, root. Note the plant part: root oil, in a trade that sells bark, root and stem under one name.
9. Beta-sitosterol pharmacology and dosing. PubMed topic search — human, isolated compound. Read the doses used, then ask whether a bark capsule could plausibly deliver them.
10. Herb–drug interaction assessment methods. PubMed topic search — methods. The standard screening approach that has never been applied to this plant, which is why "unknown" rather than "none" is the correct interaction statement.
11. Heavy metals and contaminants in wild-harvested herbal material. PubMed topic search — analytical. Relevant to a woody drug prepared by prolonged boiling and never surveyed.
12. Under-reporting of herbal adverse events. PubMed topic search — pharmacovigilance. The evidence that "no case reports" reflects surveillance rather than safety.

Back to Table of Contents

External Resources

• FDA: Health Fraud Scams — public warnings and lists of products found to contain hidden drug ingredients.
• National Center for Complementary and Integrative Health — plain-language safety summaries for botanicals.
• MedlinePlus — the US National Library of Medicine's consumer health portal, including its herbs and supplements section.
• United States Pharmacopeia and NSF — independent supplement verification programmes.
• PubMed — the index behind every search above.

Back to Table of Contents

Connections

• All Herbs
• Muira Puama — main article
• Muira Puama Benefits — hub
• Which Plant Is Muira Puama?
• Muira Puama for Libido: Examining the Claims
• Muira Puama for Fatigue, Mood and Memory
• Tongkat Ali: Product Quality and Adulteration
• Epimedium: Safety, Adulteration and Product Quality
• Tribulus: Saponins, Quality and Safety
• Damiana: Cyanogenic Glycosides, Dose and Safety
• Ginkgo Biloba
• Erectile Dysfunction
• Low Testosterone and TRT
• Chronic Fatigue Syndrome
• Arginine: Erectile Function
• Ginseng
• Maca

Back to Table of Contents